HPV Vaccine in the Child Vaccination Program

Folkehelseinstituttet

Folkehelseinstituttet [the Norwegian Institute of Public Health’is carrying out an open tender competition with the aim of entering into a framework agreement for the delivery of HPV vaccines i.e. The vaccine against human papillomavirus, for boys and girls in the Norwegian child vaccination program.
The competition will be implemented as an open tender competition in accordance with the Public Procurement Regulations' Parts 1 and 3. The competition is implemented electronically in CTM electronic tender documentation tool (KGV).
Together with information given in KGV and announcements on Doffin and TED, the basis of competition is determined with attachments, rules and conditions for the competition.
The purpose of the procurement is to enter into a framework agreement for the delivery of HPV vaccinations, i.e. vaccinations again the human papillomavirus in the Norwegian child vaccination programme. The target group is girls and boys aged 12-13 years. The procurement will be carried out as an open tender competition.
The procurement concerns the delivery of vaccines against human papillomavirus (HPV) (ATC code, J07B M).

Frist

Fristen for mottak av tilbud var 2020-09-15. Anskaffelsen ble publisert 2020-07-07.

Leverandører

Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:

• GlaxoSmithKline AS

Hvem?

• Folkehelseinstituttet

Hva?

• Antiinfektive midler for systemisk bruk › Vaksiner

Hvor?

• Norge

Anskaffelseshistorikk

Dato	Dokument
2020-07-07	Kunngjøring av konkurranse
2021-01-19	Kunngjøring om tildeling av kontrakt

Kunngjøring av konkurranse (2020-07-07)
Gjenstand
Anskaffelsens omfang
Tittel: Vaccines
Referansenummer: 20/12382
Kort beskrivelse:

Folkehelseinstituttet [the Norwegian Institute of Public Health’is carrying out an open tender competition with the aim of entering into a framework agreement for the delivery of HPV vaccines i.e. The vaccine against human papillomavirus, for boys and girls in the Norwegian child vaccination program. The competition will be implemented as an open tender competition in accordance with the Public Procurement Regulations' Parts 1 and 3. The competition is implemented electronically in CTM electronic tender documentation tool (KGV). Together with information given in KGV and announcements on Doffin and TED, the basis of competition is determined with attachments, rules and conditions for the competition. The purpose of the procurement is to enter into a framework agreement for the delivery of HPV vaccinations, i.e. vaccinations again the human papillomavirus in the Norwegian child vaccination programme. The target group is girls and boys aged 12-13 years. The procurement will be carried out as an open tender competition. The procurement concerns the delivery of vaccines against human papillomavirus (HPV) (ATC code, J07B M).

Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner 📦
Tilleggs-CPV: Vaksiner 📦
Utførelsessted
NUTS-region: Norge 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Folkehelseinstituttet
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21076629 📞
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=274075&B=DFO 🌏
URL for deltakelse: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=274075&B=DFO 🌏

Referanse
Datoer
Sendt dato: 2020-07-07 📅
Innleveringsfrist: 2020-09-15 📅
Publiseringsdato: 2020-07-10 📅
Identifikatorer
Kunngjøringsnummer: 2020/S 132-325021
OJ-S-utgave: 132
Tilleggsinformasjon

See point VI.3), Additional information for clarification regarding estimated procurement value in point II.1.5) ‘Estimated total value’.

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:

The competition will be implemented as an open tender competition in accordance with the Public Procurement Regulations' Parts 1 and 3. The competition is implemented electronically in CTM electronic tender documentation tool (KGV).

Together with information given in KGV and announcements on Doffin and TED, the basis of competition is determined with attachments, rules and conditions for the competition.

The purpose of the procurement is to enter into a framework agreement for the delivery of HPV vaccinations, i.e. vaccinations again the human papillomavirus in the Norwegian child vaccination programme. The target group is girls and boys aged 12-13 years. The procurement will be carried out as an open tender competition.

The procurement concerns the delivery of vaccines against human papillomavirus (HPV) (ATC code, J07B M).

Estimert totalverdi: 100 000 000 NOK 💰
Kort beskrivelse:

In conjunction with information given in KGV and announced on Doffin and TED, this determines the basis for the tender documentation and Appendix, rules and terms for the competition.

The Norwegian Institute of Public Health will, in accordance with the contract, register at a minimum volume 110 000 doses per calendar year in the contract period. (Supply agreement point 3.2). The tenderer will commit to being able to deliver up to 130 000 doses per calendar years in the contract period. (Supply agreement point 3.3)

With a maximum contract duration of 4 years, the scope is 444 000-520 000.

Beyond the minimum volume, the volume that the Norwegian Public Health Authority will eventually o order, depending on request.

The Norwegian Public Health Institute is not obligated to submit orders beyond the minimum requirement.

Estimert verdi eksklusive mva: 100 000 000 NOK 💰
Varighet: 24 måneder
Beskrivelse av fornyelser:

The contract will have a duration of 2 years with automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with supply agreement point 17. The contracting authority aims to sign the contract shortly after the procurement is implemented.

Beskrivelse av opsjoner:

The contract will have a duration of 2 years with automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with Supply Agreement point 17. The contracting authority aims to sign the contract shortly after the procurement is implemented.

Tilleggsinformasjon:

See point VI.3), Additional information for clarification regarding estimated procurement value in point II.1.5) ‘Estimated total value’.

Utførelsessted
Hovedsted eller utførelsessted: Oslo.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:

Tenderers must be registered in a company register, professional register or a trade register in the country where the tenderer is established.

Documentation requirement:

Norwegian tenderers: Company Registration Certificate

Foreign tenderers: Verification showing that the tenderer is registered in a company register, professional register or a commerce register in the country where the tenderer is established.

Økonomisk og finansiell stilling:

Sufficient economic and financial capacity to be able to fulfil the contract. Creditworthiness with no requirement for guarantees will be sufficient to meet the requirement.

Documentation requirement:

Credit rating based on the most recent accounting figures. The rating must be carried out by a credit rating company with a license to conduct this service.

If a tenderer has valid reasons for not being able to provide the documentation requested by the contracting authority, the tenderer can prove his economic and financial position with any other document that the contracting authority deems suitable.

Teknisk og faglig kapasitet:

Tenderers must have experience from comparable assignments.

Documentation requirement:

Description of up to three of the tenderer's most relevant assignments during the last 3 years. The description must include an indication of the assignment product/scope or value, dates and recipients.. It is the tenderer's responsibility to confirm relevance through the description.

The tenderer must have sufficient delivery capacity throughout the contract period.

Proof that the tenderer has the capacity to deliver up to 130 000 doses of HPV vaccine per year through the contract period.

The tenderer must have the requisite permissions to be able to fulfil the contract.

If the tenderer is the manufacturer of the vaccine, permission must be presented from relevant EU/EEA authorities to manufacture pharmaceuticals.

If the tenderer is not the manufacturer of the vaccine, the requisite permissions from relevant EU/EEA authorities to trade in pharmaceuticals must be presented.

If the tenderer imports the vaccine, the import license that includes the offered vaccine must be presented.

Kontraktutførelse
Vilkår for kontraktoppfyllelse:

• The Norwegian Institute of Public Health requires ethical and socially responsible production. (Supply Agreement, point 12, 12.1 – 12.4)

• The tenderer shall be a member of the Legemiddelansvarsforeningen [Pharmaceutical Liability Association] (Supply Agreement, point 11.2)

•The Norwegian Institute of Public Health can re-sell, non-distributed, vaccine doses (Supply Agreement, point 18.1)

• The tenderer must be able to deliver up to 130 000 doses per year during the contract period. (Supply agreement point 3.3)

• The Norwegian Institute of Public Health is obliged to procure a minimum of 110 000 doses per year during the contract period. (Supply agreement point 3.2)

Prosedyre
Rettslig grunnlag: 32014L0024
Tidspunkt for mottak av tilbud: 13:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: engelsk 🗣️
norsk 🗣️
Tilbudets gyldighetsperiode: 2020-11-15 📅
Dato for åpning av tilbud: 2020-09-15 📅
Tidspunkt for åpning av tilbud: 13:00
Sted: Electronic tender opening in the KGV system.
Tilleggsinformasjon:

Two persons from the Norwegian Institute of Public Health's vaccination management unit.

Tildelingskriterier
Kvalitetskriterium (navn): Quality, including effect and security
Kvalitetskriterium (vekting): 70
Pris (vekting): 30

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983 744 516
Kontakt
Kontaktpunkt: Ole Andreas Fuglesang
Adresse til kjøperprofilen: https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372 🌏
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=274075&B=DFO 🌏

Referanse
Tilleggsinformasjon

About the procurement Value, cf. point II.1.5) Estimated total value.

The total value of the procurement is roughly given as NOK 100 million, with the following clarification:

The contracting authority has calculated a span for real procurement value based on prices offered in the previous tender competition. In the Norwegian Institute of Public Health's vaccine procurements, price per dost unit price) is the only price element. As the total doses are known, it is not possible to provide exact values for the procurement value without the unit prices quoted in the previous tender being known. The contracting authority considers unit prices as information of competitive importance to keep confidential for the purposes of the information concerned and that they are covered by confidentiality cf. confidentiality, cf. the Freedom of Information Act 13 and the Public Administration Act §13 first paragraph point 2).

The contracting authority notes that the estimated cost range of the procurement value is from under to over NOK 100 million where the sales are in the size order of tens of millions both ways (over and under).

Utfyllende informasjon
Klageinstans
Navn: Oslo tingrett
Postadresse: Postboks 2106 Vika
Poststed: Oslo
Postnummer: 0125
Land: Norge 🇳🇴
Telefon: +47 22035200 📞
E-post: oslo.tingrett@domstol.no 📧
Internettadresse: https://www.domstol.no/Enkelt-domstol/oslotingrett/ 🌏
Kilde: OJS 2020/S 132-325021 (2020-07-07)

Kunngjøring om tildeling av kontrakt (2021-01-19)
Gjenstand
Anskaffelsens omfang
Kort beskrivelse:

The Norwegian Institute of Public Health has held an open tender contest and entered into a framework agreement for the delivery of HPV vaccines, i.e., the vaccine against human papillomavirus, for boys and girls in the Norwegian child vaccination programme. The contest was held as an open tender contest in accordance with the Act and Public Procurement Regulations Parts 1 and 3. The contest was held electronically in the CTM electronic tender documentation tool (Norwegian abbreviation: KGV). Together with information given in the KGV and announcements on Doffin and TED, the tender documentation with annexes set the rules and conditions for the contest. The purpose of the procurement was to enter into a framework agreement for the delivery of HPV vaccinations, i.e., vaccinations against the human papillomavirus in the Norwegian child vaccination programme. The target group is girls and boys aged 12-13 years. The procurement concerns the delivery of vaccines against human papillomavirus (HPV) (ATC code, J07B M). One tender was received in this contest.

Totalverdi for anskaffelsen: 100 000 000 NOK 💰
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt

Prosedyre
Tilbudstype: Ikke aktuelt

Referanse
Datoer
Sendt dato: 2021-01-19 📅
Publiseringsdato: 2021-01-22 📅
Identifikatorer
Kunngjøringsnummer: 2021/S 015-034936
Refererer til kunngjøring: 2020/S 132-325021
OJ-S-utgave: 15
Tilleggsinformasjon

See point VI.3, Additional information for clarification regarding estimated procurement value in point II.1.5 ‘Estimated total value’.

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:

The contest was held as an open tender contest in accordance with the Act and Public Procurement Regulations Parts 1 and 3. The contest was held electronically in the CTM electronic tender documentation tool (Norwegian abbreviation: KGV).

Together with information given in the KGV and announcements on Doffin and TED, the tender documentation with annexes set the rules and conditions for the contest.

The purpose of the procurement was to enter into a framework agreement for the delivery of HPV vaccinations, i.e., vaccinations against the human papillomavirus in the Norwegian child vaccination programme. The target group is girls and boys aged 12-13 years.

One tender was received in this contest.

With a maximum contract duration of four years, the scope is 444 000 - 520 000.

Beskrivelse av opsjoner:

The contract will have a duration of two years with automatic extension for one year + one year unless it is cancelled earlier in-line with Supply Agreement point 17.

Tilleggsinformasjon:

See point VI.3, Additional information for clarification regarding estimated procurement value in point II.1.5 ‘Estimated total value’.

Prosedyre
Tildelingskriterier
Kvalitetskriterium (navn): Quality, including Effect and Security

Tildeling av kontrakt
Dato for kontraktinngåelse: 2020-11-10 📅
Navn: Glaxosmithkline as
Nasjonalt registreringsnummer: 930606308
Postadresse: Drammensveien 288
Poststed: Oslo
Postnummer: 0283
Land: Norge 🇳🇴
Telefon: +47 91520120 📞
E-post: beatricedvergsdal.x.magelssen@gsk.com 📧
Totalverdi for anskaffelsen: 1 NOK 💰
Informasjon om tilbud
Antall mottatte tilbud: 1

Referanse
Tilleggsinformasjon

About the procurement Value, cf. point II.1.5) Estimated Total Value.

Pursuant the Act relating to public access to documents in public administration Section 13 and the Public Administration Act Section 13, first section 2), the contract sum is not given in the tender notice. The vaccines' price per dosage is the only price element. The contracting authority has come the conclusion that if the contract value is given with information of the extent/volume in the tender documentation, it will be possible to calculate the price per dosage. The contracting authority considers offered prices per dosages as information that must be kept secret due for competitive reasons.

The contracting authority confirms that the contract value is higher than the procurement rules' highest threshold.

Kilde: OJS 2021/S 015-034936 (2021-01-19)

Nye anskaffelser i relaterte kategorier 🆕

Medisinsk utstyr, legemidler og utstyr til personlig pleie (>20 nye anskaffelser)

Farmasøytiske produkter (6)

Antiinfektive midler for systemisk bruk, vaksiner, cytostatika/cytotoxiske midler, samt immunmodulerende midler

Antiinfektive midler for systemisk bruk

Vaksiner